Advisory Research’s Livongo Health, Inc. Common Stock LVGO Stock Holding History

Advisory Research’s Portfolio LVGO Stock Details LVGO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q4	–	Sell	-5,197	Closed	-$728K	–	368
2020 Q3	$728K	Sell	5,197 -52,296	-91%	-$6.37M	0.07%	211
2020 Q2	$4.32M	Sell	57,493 -22,948	-29%	-$1.2M	0.38%	72
2020 Q1	$2.29M	Buy	80,441 +50,065	+165%	+$1.3M	0.16%	79
2019 Q4	$761K	Buy	+30,376	New	+$726K	0.04%	202

Advisory Research's LVGO Position: Q4 2020 in Review

Advisory Research sold out of Livongo Health, Inc. Common Stock (LVGO) in Q4 2020, closing a stake of 5,197 shares — an estimated $728K sold.

Advisory Research first reported a position in LVGO in Q4 2019 and held it in 4 quarters. The position peaked at $4.32M in Q2 2020. 0 funds tracked by Wall St. Rank hold LVGO as of Q4 2020.

Advisory Research reported no remaining Livongo Health, Inc. Common Stock position as of Q4 2020 after selling out during the quarter.
Advisory Research sold 5,197 Livongo Health, Inc. Common Stock shares in Q4 2020, an estimated $728K.
Advisory Research first reported a position in Livongo Health, Inc. Common Stock in Q4 2019 and held it in 4 quarters.
Advisory Research's Livongo Health, Inc. Common Stock position peaked at $4.32M in Q2 2020.
0 funds tracked by Wall St. Rank held Livongo Health, Inc. Common Stock as of Q4 2020.

Based on Advisory Research's 13F filing for Q4 2020, filed 12 Feb 2021.